Assessment of the stability of an immunoadsorbent for the extracorporeal removal of beta-2-microglobulin from blood

Blood Purification

Volumn 23, Issue 4, 2005, Pages 287-297

  Daniels, Cynthia M ^a   Woolverton, Emily M ^a   Sprague, Stuart M ^b,c   Ameer, Guillermo A ^a  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Division of Nephrology   (United States)

Author keywords

Beta 2 microglobulin; Dialysis related amyloidosis; End stage kidney disease

Indexed keywords

ADSORBENT; AGAROSE; ALCOHOL; BETA 2 MICROGLOBULIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; FREEZE DRYING; GEL; HEMODIALYSIS; HEMOFILTRATION; IMMUNOADSORBENT; IMMUNOADSORPTION; INSTRUMENT STERILIZATION; KIDNEY FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; STORAGE; THERMOSTABILITY;

AMYLOIDOSIS; BETA 2-MICROGLOBULIN; DRUG STABILITY; EXTRACORPOREAL CIRCULATION; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOSORBENT TECHNIQUES; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; SEPHAROSE; STERILIZATION;

EID: 24944524449     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086207     Document Type: Article

References (64)

1. Drueke TB: Beta-2-microglobulin amyloidosis. Nephrol Dial Transplant 2000;15(suppl 1):17-24.
2. Gejyo F, Yamada T, Odani S, et al: A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun 1985;129:701-706.
3. Gorevic PD, Casey TT, Stone WJ, et al: Beta-2-microglobulin is an amyloidogenic protein in man. J Clin Invest 1985;76:2425-2429.
4. Vinhas J, Pinto dos Santos J: Haemodialyser reuse: Facts and fiction. Nephrol Dial Transplant 2000;15:5-8.
5. Sprague SM, Moe SM: Clinical manifestations and pathogenesis of dialysis-related amyloidosis. Semin Dial 1996;9:360-369.
6. Gates FT 3rd, Coligan JE, Kindt TJ: Complete amino acid sequence of murine beta 2-microglobulin: Structural evidence for strain-related polymorphism. Proc Natl Acad Sci USA 1981;78:554-558.
7. Trinh CH, Smith DP, Kalverda AP, Phillips SE, Radford SE: Crystal structure of monomeric human beta-2-microglobulin reveals clues to its amyloidogenic properties. Proc Natl Acad Sci USA 2002;99:9771-9776.
8. Floege J, Ehlerding G: Beta-2-microglobulin-associated amyloidosis. Nephron 1996;72:9-26.
9. Ameer GA: Modalities for the removal of beta 2-microglobulin from blood. Semin Dial 2001;14:103-106.
10. Furuyoshi S, Nakatani M, Taman J, Kutsuki H, Takata S, Tani N: New adsorption column (Lixelle) to eliminate beta-2-microglobulin for direct hemoperfusion. Ther Apher 1998;2:13-17.
11. Morena MD, Guo D, Balakrishnan VS, Brady JA, Winchester JF, Jaber BL: Effect of a novel adsorbent on cytokine responsiveness to uremic plasma. Kidney Int 2003;63:1150-1154.
12. Suzuki K, Shimazaki M, Kutsuki H: Beta-2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis. Ther Apher Dial 2003;7:104-107.
13. Tsuchida K, Takemoto Y, Nakamura T, et al: Lixelle adsorbent to remove inflammatory cytokines. Artif Organs 1998;22:1064-1067.
14. Tsuchida K, Takemoto Y, Sugimura K, Yoshimura R, Yamamoto K, Nakatani T: Adsorption of endotoxin by beta2-microglobulin adsorbent column (Lixelle): The new approach for endotoxinemia. Ther Apher 2002;6:116-118.
15. Tsuchida K, Takemoto Y, Sugimura K, Yoshimura R, Nakatani T: Direct hemoperfusion by using Lixelle column for the treatment of systemic inflammatory response syndrome. Int J Mol Med 2002;10:485-488.
16. Canaud B, Bosc JY, Leray-Moragues H, et al: On-line haemodiafiltration. Safety and efficacy in long-term clinical practice. Nephrol Dial Transplant 2000;15(suppl 1):60-67.
17. Jaradat MI, Moe SM: Effect of hemodialysis membranes on beta-2-microglobulin amyloidosis. Semin Dial 2001;14:107-112.
18. Lee WC, Uchino S, Fealy N, et al: Beta2-microglobulin clearance with super high flux hemodialysis: An ex vivo study. Int J Artif Organs 2003;26:723-727.
19. Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P: On-line haemodiafiltration: Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant 2000;15(suppl 1):49-54.
20. Mogi M, Harada M, Kojima K, Adachi T, Nakamura S: Selective removal of beta 2-microglobulin from plasma specimens of long-term hemodialysis patients by high-performance immunoaffinity chromatography. Clin Chem 1993;39:277-280.
21. Wizemann V, Lotz C, Techert F, Uthoff S: On-line haemodiafiltration versus low-flux haemodialysis: A prospective randomized study. Nephrol Dial Transplant 2000;15(suppl 1):43-48.
22. Vallar L, Costa PM, Teixeira A, et al: Immunoadsorption procedure as a potential method for the specific beta-2-microglobulin removal from plasma of patients with chronic renal failure. J Chromatogr [B] 1995;664:97-106.
23. Nakano H, Gomi H, Shibasaki T, Ishimoto F, Sakai O: An experimental study on selective elimination of beta-2-microglobulin using immunoadsorption method in patients with chronic renal failure. Biomater Artif Cells Immobilization Biotechnol 1991;19:61-69.
24. Reiter K, Bordoni V, Dall'Olio G, et al: In vitro removal of therapeutic drugs with a novel adsorbent system. Blood Purif 2002;20:380-388.
25. Shabunina IV, Afanas'eva OI, Pokrovskii SN: Immunosorbent for removal of b2-microglobulin from human blood plasma. Bull Exp Biol Med 2001;132:984-986.
26. Winchester JF, Kellum JA, Ronco C, et al: Sorbents in acute renal failure and the systemic inflammatory response syndrome. Blood Purif 2003;21:79-84.
27. Winchester JF, Silberzweig J, Ronco C, et al: Sorbents in acute renal failure and end-stage renal disease: Middle molecule and cytokine removal. Blood Purif 2004;22:73-77.
28. Ronco C, Brendolan A, Winchester JF, et al: First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta 2-microglobulin in hemodialysis. Contrib Nephrol. Basel, Karger, 2001, vol 133, pp 166-173.
29. Davankov V, Pavlova L, Tsyurupa M, Brady J, Balsamo M, Yousha E: Polymeric adsorbent for removing toxic proteins from blood of patients with kidney failure. J Chromatogr [B] 2000;739:73-80.
30. Davankov V, Tsyurupa M, Ilvin M, Pavlova L: Hypercross-linked polystyrene and its potentials for liquid chromatography: A mini-review. J Chromatogr [A] 2002;965:65-73.
31. Winchester JF, Salsberg JA, Levin NW: Beta-2 microglobulin in ESRD: An in-depth review. Adv Ren Replace Ther 2003;10:279-309.
32. Ronco C, Ghezzi P, Morris A, et al: Blood flow distribution in sorbent beds: Analysis of a new sorbent device for hemoperfusion. Int J Artif Organs 2000;23:125-130.
33. Grovender EA, Kellogg B, Singh J, et al: Single-chain antibody fragment-based adsorbent for the extracorporeal removal of beta2-microglobulin. Kidney Int 2004;65:310-322.
34. McCullough NB: Laboratory tests in the diagnosis of brucellosis. Am J Publ Health 1949;39:866-869.
35. Spink WW: The laboratory diagnosis of brucellosis. Am J Clin Pathol 1952;22:201-210.
36. Hedgecock LW: Effect of vaccines prepared from Histoplasma capsulatum and other yeasts on experimental tuberculosis. J Bacteriol 1961;82:115-123.
37. Garrison RG: Studies of the respiratory activity of Histoplasma capsulatum. I. Aspects of the aerobic metabolism of the yeast phase. J Infect Dis 1961;108:120-124.
38. Federal Drug & Administration: Bacteriological Analytical Manual, ed 8. Gaithersburg, AOAC International, 1995.
39. Downes FP, Ito K: Compendium of Methods for the Microbiological Examination of Foods, ed 4. Washington, APHA, 2001.
40. Horwitz W: Official Methods of Analysis of AOAC International, ed 17. Washington, APHA, 2002.
41. Marshall RT: Standard Method of Analysis of AOAC International, ed 16. Washington, APHA, 1993.
42. Clesceri LS, Greenberg AE, Eaton AD: Standard Methods for the Examination of Water and Wastewater, ed 20. Washington, APHA, 1998.
43. Association for the Advancement of Medical Instrumentation (AAMI): Standards and recommended practices for reuse of hemodialyzers. Arlington, 1993, pp 106-107.
44. Miyata T, Inagi R, Kurokawa K: Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis. Miner Electrolyte Metab 1999;25:114-117.
45. Nangaku M, Miyata T, Kurokawa K: Pathogenesis and management of dialysis-related amyloid bone disease. Am J Med Sci 1999;317:410-415.
46. Wada T, Miyata T, Sakai H, Kurokawa K: Beta2-microglobulin and renal bone disease. Peril Dial Int 1999;19(suppl 2):S413-S416.
47. Kandus A, Malovrh M, Bren AF: Influence of blood flow on adsorption of beta-2-microglobulin onto AN69 dialyzer membrane. Artif Organs 1997;21:903-906.
48. Ronco C, Brendolan A, Cappelli G, et al: In vitro and in vivo evaluation of a new polysulfone membrane for hemodialysis: Reference methodology and clinical results. 2. In vivo study. Int J Artif Organs 1999;22:616-624.
49. Ronco C, Brendolan A, Cappelli G, et al: In vitro and in vivo evaluation of a new polysulfone membrane for hemodialysis. Reference methodology and clinical results. 1 In vitro study. Int J Artif Organs 1999;22:604-615.
50. Ameer GA, Grovender EA, Ploegh H, et al: A novel immunoadsorption device for removing beta-2-microglobulin from whole blood. Kidney Int 2001;59:1544-1550.
51. Ameer GA, Barabino G, Sasisekharan R, Hamon W, Cooney CL, Langer R: Ex vivo evaluation of a Taylor-Couette flow, immobilized heparinase I device for clinical application. Proc Natl Acad Sci USA 1999;96:2350-2355.
52. Bigi A, Coiazzi G, Panzavolta S, Roveri N, Rubini K: Stabilization of gelatin films by cross-linking with genipin. Biomaterials 2002;23:4827-4832.
53. Billiar K, Murray J, Laude D, Abraham G, Bachrach N: Effects of carbodiimide crosslinking conditions on the physical properties of laminated intestinal submucosa. J Biomed Mater Res 2001;56:101-108.
54. Dosanjh NS, Kaur J: Immobilization, stability and esterification studies of a lipase from a Bacillus sp. Biotechnol Appl Biochem 2002;36:7-12.
55. Goissis G, Yoshioka SA, Braile DM, Ramirez VD: The chemical protecting group concept applied in crosslinking of natural tissues with glutaraldehyde acetals. Artif Organs 22:210-214.
56. Stragier A: Dialyzer reuse: The debate continues. Nephrol News Issues 2003;17:97.
57. Agodoa LY, Wolfe RA, Port FK: Reuse of dialyzers and clinical outcomes: Fact or fiction. Am J Kidney Dis 1998;32(suppl 4):S88-S92.
58. Hay JE, Cockerill FR 3rd, Kaese D, et al: Clinical comparison of isolator, Septi-Chek, non-vented tryptic soy broth, and direct agar plating combined with thioglycolate broth for diagnosing spontaneous bacterial peritonitis. J Clin Microbiol 1996;34:34-37.
59. Chang JC, Oshida Y, Gregory RL, Andres CJ, Barco TM, Brown DT: Electrochemical study on microbiology-related corrosion of metallic dental materials. Biomed Mater Eng 2003;13:281-295.
60. Muhammad N, Hooke AM: Toxicity of heavy metals for microorganisms isolated from slow sand filter schmutzdecke. Environ Technol 2003,24:1097-1102.
61. Neppelenbroek KH, Pavarina AC, Spolidorio DM, Vergani CE, Mima EG, Machado AL: Effectiveness of microwave sterilization on three hard chairside reline resins. Int J Prosthodont 2003;16:616-620.
62. Allison SD, Molina MC, Anchordoquy TJ: Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: The particle isolation hypothesis. Biochim Biophys Acta 2000;1468:127-138.
63. Allison SD, Anchordoquy TJ: Mechanisms of protection of cationic lipid-DNA complexes during lyophilization. J Pharm Sci 2000;89:682-691.
64. Molina MC, Allison SD, Anchordoquy TJ: Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: Insight from other structural indicators. J Pharm Sci 2001;90:1445-1455.